for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Relx PLC

REL.L

Latest Trade

2,196.00GBp

Change

-2.00(-0.09%)

Volume

6,788,932

Today's Range

2,180.00

 - 

2,220.00

52 Week Range

1,505.00

 - 

2,220.00

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
2,198.00
Open
2,211.00
Volume
6,788,932
3M AVG Volume
48.10
Today's High
2,220.00
Today's Low
2,180.00
52 Week High
2,220.00
52 Week Low
1,505.00
Shares Out (MIL)
1,934.38
Market Cap (MIL)
42,517.71
Forward P/E
24.87
Dividend (Yield %)
2.20

Next Event

Q3 2021 Relx PLC Trading Statement Release

Latest Developments

More

Lexisnexis Risk Solutions Awarded $1.2 Billion Blanket Purchasing Agreement With U.S. Department Of Labor

Relx Confirms Paul Walker Appointment As Co's Chair

Relx Says Paul Walker To Succeed Anthony Habgood As Chair

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Relx PLC

RELX PLC is a holding company of RELX Group plc. RELX Group is a global provider of information and analytics for professional and business customers across industries. The Company operates in four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal, and Exhibitions. The Company's Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals progress science and advance healthcare. The Risk & Business Analytics segment provides solutions and decision tools that combine public and industry-specific content with technology and analytics. The Legal segment is a provider of information and analytics to professionals in legal, corporate, and government organizations. Its Exhibitions segment consists of Reed Exhibitions, which is an exhibitions business, with events in over 30 countries.

Industry

Printing & Publishing

Contact Info

Grand Buildings, 1-3 Strand

WC2N 5JR

United Kingdom

+44.20.71665500

https://www.relx.com/

Executive Leadership

Paul Walker

Non-Executive Chairman of the Board

Erik Engstrom

Chief Executive Officer, Executive Director

Nicholas Lawrence Luff

Chief Financial Officer, Executive Director

Kumsal Bayazit Besson

Chief Executive Officer - Scientific, Technical & Medical and Chairwoman, RELX Technology Forum

Youngsuk Chi

Director - Corporate Affairs and Chairman Elsevier

Key Stats

2.20 mean rating - 20 analysts
Sell
Hold
Buy
Revenue (MM, GBP)

2018

7.5K

2019

7.9K

2020

7.1K

2021(E)

7.3K
EPS (GBp)

2018

84.700

2019

93.000

2020

80.100

2021(E)

87.077
Price To Earnings (TTM)
31.78
Price To Sales (TTM)
6.07
Price To Book (MRQ)
17.51
Price To Cash Flow (TTM)
20.66
Total Debt To Equity (MRQ)
267.56
LT Debt To Equity (MRQ)
248.80
Return on Investment (TTM)
13.41
Return on Equity (TTM)
9.38

Latest News

Latest News

Demand for analytics helps UK's Relx to lift 2021 outlook

The UK's Relx expects 2021 underlying growth rates to be slightly above historical trends due to strong demand for its analytics and fraud prevention services, helping the information provider increase its dividend.

UPDATE 2-Relx raises dividend after pandemic drives analytics demand

* Outlook for exhibitions remains uncertain (Adds shares, background)

FTSE 100 gains on upbeat AstraZeneca results

London's FTSE 100 gained on Thursday boosted by drugmaker AstraZeneca's upbeat quarterly results and as information group Relx planned to raise its dividend.

Information group Relx proposes 3% dividend hike

European information business provider Relx said it expected its three main divisions covering science, legal and risk to return to pre-COVID profit trends in 2021, enabling it to propose a 3% increase to the dividend.

CORRECTED-UPDATE 1-Relx points to hefty annual losses for exhibitions business

European information business Relx Plc said on Thursday annual revenue could fall as much as 210 million pounds ($276.09 million) short of costs in its exhibitions business, as it suffered from coronavirus-driven halts in major events this year.

CORRECTED-Relx points to hefty annual losses for exhibitions business

European information business Relx Plc said on Thursday annual revenue could fall as much as 210 million pounds ($276.09 million) short of costs in its exhibitions business, as it suffered from coronavirus-driven halts in major events this year.

UPDATE 1-Publisher Springer Nature again postpones flotation - source

Springer Nature is again postponing its plans to float on the German stock market after the coronavirus pandemic dealt a blow to parts of its business in the first half of the year, a source familiar with the matter said on Monday.

Publisher Springer Nature again postpones flotation - source

Springer Nature is again postponing its plans to float on the German stock market after the coronavirus pandemic dealt a blow to its business in the first half of the year, a source familiar with the matter said on Monday.

Relx snaps up UK's pharma analysis group SciBite

European information group Relx <REL.L> has agreed to buy Britain's SciBite, a provider of big data analytics in the pharmaceutical and healthcare industries, as part of its drive towards more digital analysis.

UPDATE 2-Relx sales fall as virus hits events business

European information group Relx said on Thursday its revenue fell 10% in the first half of the year as the coronavirus pandemic halted public meetings, hitting the London-listed company's exhibitions arm.

Relx half-year sales fall 10% as virus hits events arm

Relx said on Thursday its revenue fell 10% in the first half of 2020 as the coronavirus pandemic forced countries to halt public events and gatherings, hitting the European information group's exhibitions arm.

Britain's Relx scraps guidance on hit to exhibitions business

European information group Relx said it could not provide full-year guidance for the group due to the significant impact the coronavirus pandemic was having on its exhibitions arm.

Relx postpones nine China exhibitions, wider virus impact unclear

European information group Relx <REL.L> said it could not yet predict how coronavirus would hit its exhibitions business in China after it was forced to reschedule nine events in the country because of the outbreak.

Relx enjoys solid start to 2020, exhibitions seen trading in line

European information group Relx said the key business trends in the early part of 2020 were in line with last year as it reported organic revenue growth of 4%, in line with its recent average.

Relx spends $480 million on latest fraud spotter, Emailage

European information provider Relx Plc <REL.L> has agreed to buy U.S. company Emailage for around $480 million in its latest deal to boost the fraud detection capabilities of its fastest-growing division, a source close to the company said.

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Monday:

Relx snaps up ID Analytics for $375 million

European information provider Relx <REL.L> has agreed to buy U.S.-based ID Analytics for $375 million to further boost its ability to spot fraud and produce credit scores for its fastest-growing risk division.

Chinese e-cigarette firm Relx to open 10,000 stores within three years

E-cigarette company Relx Technology said on Saturday it will open 10,000 stores globally over the next three years in a big expansion for the Chinese vaping startup.

Relx sees solid business growth continuing in 2019

European information and analytics provider Relx said business trends in the beginning of 2019 had continued in line with its 2018 performance as it reported an as-expected 4 percent rise in underlying revenue growth.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up